APOTES Income Statement - TTM - Apotea AB (publ)

Income Statement (TTM)

Apotea AB (publ) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2021 12-31	2022 12-31	2023 12-31	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	4,580	4,883	5,455	6,304	6,547	6,778	6,944
Change (%)		6.62	11.72	15.56	3.85	3.54	2.43
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	3,384	3,611	4,001	4,577	4,753	4,915	5,030
Change (%)		6.71	10.80	14.37	3.85	3.41	2.34
% of Revenue	73.90	73.96	73.35	72.60	72.60	72.51	72.45

Gross Operating Profit	1,195	1,271	1,454	1,728	1,794	1,863	1,913
Change (%)		6.38	14.35	18.83	3.83	3.89	2.67
% of Revenue	26.10	26.04	26.65	27.40	27.40	27.49	27.55

SG&A	1,044	1,182	1,248	1,363	1,412	1,443	1,469
Change (%)		13.25	5.57	9.24	3.64	2.16	1.81
% of Revenue	22.79	24.20	22.87	21.62	21.58	21.29	21.16

R&D
Change (%)
% of Revenue

OpEx	4,445	4,834	5,342	6,048	6,284	6,486	6,626
Change (%)		8.74	10.52	13.20	3.90	3.21	2.17
% of Revenue	97.07	99.00	97.93	95.93	95.99	95.68	95.43

Operating Income	134	49	113	256	263	293	317
Change (%)		-63.54	130.20	127.22	2.54	11.49	8.23
% of Revenue	2.93	1.00	2.07	4.07	4.01	4.32	4.57

Interest Expense	-3	-4	-5	-4	-5	-7	-9
Change (%)		11.76	21.05	-10.87	29.27	28.30	26.47
% of Revenue	-0.07	-0.08	-0.08	-0.07	-0.08	-0.10	-0.12

Net Income	105	20	87	192	215	238	249
Change (%)		-81.03	337.19	121.15	11.69	10.66	4.84
% of Revenue	2.29	0.41	1.59	3.05	3.28	3.51	3.59

Source: Capital IQ

Apotea AB (publ) - Income Statement (TTM)

Income Statement (TTM)

Other Listings

SE:APOTEA	SEK96.15
DE:V30